Association of group A streptococcal emm types with virulence traits and macrolide-resistance genes is independent of the source of isolation

References

1. Albrich W. C., Monnet D. L., Harbath S. 2004; Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes . Emerg Infect Dis 10:514–517 [CrossRef]
   [Google Scholar]
2. Banks D. J., Beres S. B., Musser J. M. 2002; The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol 10:515–521 [CrossRef]
   [Google Scholar]
3. Banks D. J., Porcella S. F., Barbian K. D. & 7 other authors; 2004; Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. J Infect Dis 190:727–738 [CrossRef]
   [Google Scholar]
4. Bessen D. E., Sotir C. M., Readdy T. L., Hollingshead S. K. 1995; Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 173:896–900
   [Google Scholar]
5. Bessen D. E., Izzo M. W., Fiorentino T. R., Caringal R. M., Hollingshead S. K., Beall B. 1999; Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. J Infect Dis 179:627–636 [CrossRef]
   [Google Scholar]
6. Broudy T. B., Pancholi V., Fischetti V. A. 2001; Induction of lysogenic bacteriophage and phage-associated toxin from group A streptococci during coculture with human pharyngeal cells. Infect Immun 69:1440–1443 [CrossRef]
   [Google Scholar]
7. Brussow H., Canchaya C., Hardt W.-D. 2004; Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68:560–602 [CrossRef]
   [Google Scholar]
8. Cardona F., Orefici G. 2000; Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 138:71–75
   [Google Scholar]
9. Cleary P. P., Johnson Z. 1977; Possible dual function of M protein: resistance to bacteriophage A25 and resistance to phagocytosis by human leukocytes. Infect Immun 16:280–292
   [Google Scholar]
10. Cocuzza C. E., Mattina R., Mazzariol A. & 8 other authors; 1997; High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study. Microb Drug Resist 3:371–378 [CrossRef]
    [Google Scholar]
11. Creti R., Cardona F., Pataracchia M., von Hunolstein C., Cundari G., Romano A., Orefici G. 2004; Characterisation of group A streptococcal (GAS) isolates from children with tic disorders. Indian J Med Res 119:Suppl.174–178
    [Google Scholar]
12. DelVecchio A., Maley M., Currie B. J., Sriprakash K. S. 2002; NAD-glycohydrolase production and speA and speC distribution in group A streptococcus (GAS) isolates do not correlate with severe GAS diseases in the Australian population. J Clin Microbiol 40:2642–2644 erratum 40, 4405
    [Google Scholar]
13. Descheemaeker P., van Loock F., Hauchecorne M., Vandamme P., Goossens H. 2000; Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993–1994. J Med Microbiol 49:467–471
    [Google Scholar]
14. Dicuonzo G., Gherardi G., Lorino G., Angeletti S., De Cesaris M., Fiscarelli E., Bessen D. E., Beall B. 2001; Group A streptococcal genotypes from pediatric throat isolates in Rome, Italy. J Clin Microbiol 39:1687–1690 [CrossRef]
    [Google Scholar]
15. Dicuonzo G., Fiscarelli E., Gherardi G., Lorino G., Battistoni F., Landi S., De Cesaris M., Petitti T., Beall B. 2002; Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother 46:3987–3990 [CrossRef]
    [Google Scholar]
16. Doktor S. Z., Beyer J. M., Flamm R. K., Shortridge V. D. 2005; Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes . J Clin Microbiol 43:150–155 [CrossRef]
    [Google Scholar]
17. Freeman A. F., Shulman S. T. 2002; Macrolide resistance in group A Streptococcus. Pediatr Infect Dis J 21:1158–1160 [CrossRef]
    [Google Scholar]
18. Haukness H. A., Tanz R. R., Thomson R. B. & 7 other authors; 2002; The heterogeneity of endemic community pediatric group A streptococcal pharyngeal isolates and their relationship to invasive isolates. J Infect Dis 185:915–920 [CrossRef]
    [Google Scholar]
19. Hauser A. R., Stevens D. L., Kaplan E. L., Schlievert P. M. 1991; Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 29:1562–1567
    [Google Scholar]
20. McCormick J. K., Schlievert P. M. 2000; Toxins and superantigens of group A streptococci. In Gram-positive Pathogens pp 43–52 Edited by Fischetti V. A, Novick R. P, Ferretti J. J, Portnoy D. A, Rood J. I. Washington, DC: American Society for Microbiology;
    [Google Scholar]
21. Miyoshi-Akiyama T., Zhao J., Kikuchi K., Kato H., Suzuki R., Endoh M., Uchiyama T. 2003; Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci. J Infect Dis 187:1876–1887 [CrossRef]
    [Google Scholar]
22. Mylvaganam H., Bjorvatn B., Osland A. 2000; Distribution and sequence variations of selected virulence genes among group A streptococcal isolates from western Norway. APMIS 108:771–778 [CrossRef]
    [Google Scholar]
23. Nandi S., Chakraborti A., Bakshi D. K., Rani A., Kumar R., Ganguly N. K. 2002; Association of pyrogenic exotoxin genes with pharyngitis and rheumatic fever/rheumatic heart disease among Indian isolates of Streptococcus pyogenes . Lett Appl Microbiol 35:237–241 [CrossRef]
    [Google Scholar]
24. Orefici G., Creti R., von Hunolstein C. 2003; High frequency of group A streptococci type M89 invasive infections in Italy. In 13th European Congress of Clinical Microbiology and Infectious Diseases 10–13 May, Glasgow, UK: (abstract
    [Google Scholar]
25. Pletz M. W. R., McGee L., Beall B., Whitney C. G., Klugman K. P. 2005; Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States. Antimicrob Agents Chemother 49:779–780 [CrossRef]
    [Google Scholar]
26. Reinert R. R., Lutticken R., Bryskier A., Al-Lahham A. 2003; Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob Agents Chemother 47:489–493 [CrossRef]
    [Google Scholar]
27. Schmitz F.-J., Beyer A., Charpentier E., Normark B. H., Schade M., Fluit A. C., Hafner D., Novak R. 2003; Toxin-gene heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188:1578–1586 [CrossRef]
    [Google Scholar]
28. Suligoi B., von Hunolstein C., Orefici G., Scopetti F., Pataracchia M., Greco D. 1998; Surveillance of systemic invasive disease caused by group A Streptococcus in Italy 1994–1996. Euro Surveill 3:11–14
    [Google Scholar]
29. Tyler S. D., Johnson W. M., Huang J. C., Ashton F. E., Wang G., Low D. E., Rozee K. R. 1992; Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J Clin Microbiol 30:3127–3131
    [Google Scholar]
30. von Hunolstein C., Suligoi B., Pataracchia M., Scopetti F., Recchia S., Greco D., Orefici G. 1997; Clinical and microbiological characteristics of severe group A streptococcal infections in Italy. Adv Exp Med Biol 418:79–81
    [Google Scholar]
31. Zampaloni C., Cappelletti P., Prenna M., Vitali L. A., Ripa S. 2003; emm gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes . J Clin Microbiol 41:1307–1310 [CrossRef]
    [Google Scholar]